Why Gilead is facing criticism for political donations; what's changed since the Senate grilled drugmakers

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Gilead faces criticism for donations to state senators who backed 'Don't Say Gay' bill in Florida By Ed Silverman Yichuan Cao/Sipa USA The disclosure about Gilead funding comes amid a growing debate about pharmaceutical industry donations to politicians. Read More STAT+: Three years after the Senate grilled drugmakers … nothing's changed By Nicholas Florko Win McNamee/Getty Images This week’s Senate hearing on drug prices is a reminder of how little has changed on the issue, even as Washington keeps talking about it. Read More White House begs Congress for Covid funding amid concern about Omicron sister variant By Rachel Cohrs and Andrew Joseph CHANDAN KHANNA/AFP via Getty Images The White House is begging Congress for more funds to help with Covid-19 surveillance, testing, and treatments. Read More Sponsor content by STAT 2022 STATUS List: The most definitive and consequential accounting of leaders in health, medicine, and science Meet the STATUS List — 46 individuals shaping the future of their fields. Drawn from sectors including biotechnology and diagnostics, as well as broader arenas like education and policy, each individual has taken extra steps to help others and build community in these often-divisive times. Explore the list. STAT+: Patients are flocking back to hospitals, but volumes are at the mercy of Covid surges, new documents show By Bob Herman Nathan Howard/Getty Images The coronavirus still has a tight grip over patient volumes at hospitals, a STAT analysis of new financial documents shows. Read More Tuesday, March 15, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser